Helpful Insights forPatients and Caregivers

Nonpharmacological/Alternative Treatment Options

Download PDF

Learn more about Nonpharmacological/Alternative Treatment Options.

References

  1. National Institute of Mental Health. Brain Stimulation Therapies; 2023. Accessed September 14, 2023. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
  2. Mann SK, Malhi NK. Repetitive Transcranial Magnetic Stimulation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 6, 2023. https://www.ncbi.nlm.nih.gov/books/NBK568715/
  3. Mayo Clinic. Transcranial magnetic stimulation; 2023. Accessed September 12, 2023. https://www.mayoclinic.org/tests-procedures/transcranial-magnetic-stimulation/about/pac-20384625
  4. Koponen LM, Goetz SM, Tucci DL, Peterchev AV. Sound comparison of seven TMS coils at matched stimulation strength. Brain Stimul. 2020;13(3):873-880. doi:10.1016/j.brs.2020.03.004
  5. Gersner R, Barnea-Ygael N, Tendler A. Moderators of the response to deep TMS for smoking addiction. Front Psychiatry. 2023;13:1079138. Published 2023 Jan 9. doi:10.3389/fpsyt.2022.1079138
  6. Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger D, Daskalakis J, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: a prospective multicenter randomized double-blind placebo-controlled trial. Am J Psychiatry. (2019) 176:931–8. 10.1176/appi.ajp.2019.18101180
  7. Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R. Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review. Neuropsychiatr Dis Treat. 2020;16:2989-3000. Published 2020 Dec 7. doi:10.2147/NDT.S276635
  8. Cohen SL, Bikson M, Badran BW, George MS. A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. Brain Stimul. 2022;15(1):73-75. doi:10.1016/j.brs.2021.11.010
  9. Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder. U.S. Centers for Medicare & Medicaid Services (CMS). Last updated December 11, 2022. Accessed September 21, 2023. Available at: https://www.cms.gov/
  10. Salik I, Marwaha R. Electroconvulsive Therapy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 19, 2022. https://www.ncbi.nlm.nih.gov/books/NBK538266/
  11. What is Electroconvulsive Therapy (ECT)? American Psychiatric Association (APA). Published January 2023. Accessed September 12, 2023. https://www.psychiatry.org/patients-families/ect
  12. Bassa A, Sagués T, Porta-Casteràs D, et al. The Neurobiological Basis of Cognitive Side Effects of Electroconvulsive Therapy: A Systematic Review. Brain Sci. 2021;11(10):1273. Published 2021 Sep 26. doi:10.3390/brainsci11101273
  13. Jaffe R. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association. Am J Psychiatry. 2002;159(2):355. https://doi.org/10.1176/appi.ajp.159.2.331
  14. Electroconvulsive Therapy Review Guidelines. New York State Office of Mental Health. Published January 3, 2003. Accessed September 16, 2023. https://omh.ny.gov/omhweb/ect/guidelines.pdf
  15. Anderson IM, McAllister-Williams RH, Downey D, Elliott R, Loo C. Cognitive function after electroconvulsive therapy for depression: relationship to clinical response. Psychol Med. 2021;51(10):1647-1656. doi:10.1017/S0033291720000379
  16. Food and Drug Administration, HHS. Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses. Final order. Fed Regist. 2018;83(246):66103-66124.
  17. Emotional Freedom Technique (EFT). Kaiser Permanente. Updated June 25, 2023. Accessed September 14, 2023. https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.emotional-freedom-technique-eft.acl9225
  18. Blacher S. Emotional Freedom Technique (EFT): Tap to relieve stress and burnout. J Interprof Educ Pract. Mar 2023;30:100599. doi:10.1016/j.xjep.2023.100599
  19. Church D, House D. Borrowing Benefits: Group Treatment with Clinical Emotional Freedom Techniques Is Associated with Simultaneous Reductions in Posttraumatic Stress Disorder, Anxiety, and Depression Symptoms. J Evid Based Integr Med. 2018;23:2156587218756510. doi:10.1177/2156587218756510
  20. Church D. The EFT Manual. Fourth Edition. Fulton, CA: Energy Psychology Press; 2019.
  21. Dincer B, Inangil D. The effect of Emotional Freedom Techniques on nurses' stress, anxiety, and burnout levels during the COVID-19 pandemic: A randomized controlled trial. Explore (NY). 2021;17(2):109-114. doi:10.1016/j.explore.2020.11.012
  22. Bach D, Groesbeck G, Stapleton P, Sims R, Blickheuser K, Church D. Clinical EFT (Emotional Freedom Techniques) Improves Multiple Physiological Markers of Health. J Evid Based Integr Med. 2019;24:2515690X18823691. doi:10.1177/2515690X18823691
  23. SPRAVATO [package insert]. Janssen Pharmaceuticals, Inc.; 2019. Accessed September 17, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211243lbl.pdf
  24. Esketamine. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com. Last updated September 22, 2023. Accessed September 23, 2023.
  25. Spravato (esketamine). Johnson & Johnson. Janssen Neuroscience. Updated August 2023.  September 23, 2023. https://www.spravatohcp.com
  26. Daly EJ, Trivedi MH, Janik A, et al. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients with Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2019;76(9):893-903. doi:10.1001/jamapsychiatry.2019.1189
  27. Wang SM, Kim NY, Na HR, et al. Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis. Clin Psychopharmacol Neurosci. 2021;19(2):341-354. doi:10.9758/cpn.2021.19.2.341